在体外伤口模型上的菌体治疗和与β-乳酸抗生素结合的协同效应
Guillermo Santamaría-Corral1, John Jairo Aguilera-Correa1,2, Jaime Esteban1,2
1Clinical Microbiology Department, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, 28040 Madrid, Spain.
Antibiotics (Basel, Switzerland)
|September 28, 2024
概括
菌体与抗生素相结合,提供了一种新方法来对抗多药耐药Pseudomonas aeruginosa. 这种组合疗法有效地减少了伤口模型中的细菌生物膜,显示了局部治疗的前景.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- Pseudomonas aeruginosa 是一种主要的机会性病原体,引起各种感染.
- 在P. aeruginosa中,多药耐药性 (MDR),特别是β-乳糖耐药性,是一个重要的临床挑战.
- 细菌生物膜有助于抗微生物治疗失败和持续性感染,特别是在伤口和烧伤中.
研究的目的:
- 评估结合菌体F1Pa与贝塔乳酸抗生素对抗MDR P. aeruginosa的疗效.
- 评估这种联合治疗对细菌生物膜形成和活力的影响.
- 探索菌体F1Pa作为MDR P. aeruginosa伤口感染的局部治疗的潜力.
主要方法:
- 在MDR P. aeruginosa菌株的成熟生物膜上进行组合疗法的体外试验.
- 在体外对细菌生长抑制的评估.
- 使用临床隔离物在体外伤口模型中对生物膜减少的评估.
主要成果:
- 结合F1Pa菌体和β-乳糖抗生素,显著降低了成熟的MDR P. aeruginosa生物膜的活力.
- 结合治疗在体外抑制了细菌的生长.
- 在一个体外伤口模型中,F1Pa证明了MDR P. aeruginosa对生物膜形成的关键降低.
结论:
- 菌体F1Pa与β-乳糖抗生素相结合,是对抗MDR P. aeruginosa的一种有前途的治疗策略.
- 这种组合疗法增强了抗菌膜活性,并降低了细菌负载.
- 在伤口和烧伤中,F1Pa显示出作为MDR P. aeruginosa感染的预防性局部治疗的潜力.
相关概念视频
Lytic Cycle of Bacteriophages
70.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Lysogenic Cycle of Bacteriophages
61.9K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.9K


